EBOVAC2

Description

Development of a prophylactic Ebola vaccine using an heterologous prime-boost regimen: phase II

Accession number

f04cc090-5f11-11eb-917b-acde48001122

Project acronym

EBOVAC2

Project website

http://www.ebovac2.com/

Start date

2014-12-01

End date

2021-05-31

Funding

IMI2 - Call 2 (Grant number 115861)

Types

IMI projects

Keywords

IMI projects Infectious diseases Ebola and related diseases Vaccines Ebola+ Conducting clinical trials